NZ Psychiatry Research Review Issue 48

In this issue:

Stopping cannabis benefits psychosis outcomes
Cognitive change after firstepisode schizophrenia and other psychoses
Continuing olanzapine after remission of psychotic depression
Adjunctive anti-inflammatory drug use for schizophrenia
Comparison of 32 oral antipsychotics for multi-episode schizophrenia
Repetitive TMS for treatmentresistant depression in NZ
Societal costs of BPDs
Childhood maltreatment and treatment outcomes in psychotic disorders
Mental disorders and long-term labour market outcomes
Esketamine nasal spray + antidepressant in treatmentresistant depression

Please login below to download this issue (PDF)

Subscribe